Co-shared genomic alterations within tumors from patients with both myeloproliferative neoplasms and lymphoma.

IF 8.2 1区医学 Q1 HEMATOLOGY Haematologica Pub Date : 2024-12-01 DOI:10.3324/haematol.2023.283798

Johanne M Holst, Martin B Pedersen, Marie B Enemark, Marcus C Hansen, Patrick R Noerhave, Trine L Plesner, Henrik Frederiksen, Michael B Moeller, Stephen J Hamilton-Dutoit, Peter Noergaard, Bo K Mortensen, Hans B Ommen, Jesper Stentoft, Wayne Tam, Maja Ludvigsen, Wing C Chan, Nicolai J Birkbak, Giorgio Inghirami, Francesco D'Amore

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

骨髓增生性肿瘤和淋巴瘤患者肿瘤内的共同基因组改变。

不详。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Haematologica 医学-血液学

CiteScore

14.10

自引率

2.00%

发文量

349

审稿时长

3-6 weeks

期刊介绍： Haematologica is a journal that publishes articles within the broad field of hematology. It reports on novel findings in basic, clinical, and translational research. Scope: The scope of the journal includes reporting novel research results that: Have a significant impact on understanding normal hematology or the development of hematological diseases. Are likely to bring important changes to the diagnosis or treatment of hematological diseases.

期刊最新文献

Results from patient-derived xenograft models support co-administration of allopurinol and 6-mercaptopurine to reduce hepatotoxicity and improve event-free survival in pediatric acute lymphoblastic leukemia. Manganese overload as a co-factor of neurological symptoms in a patient with sclerosing cholangitis due to Langerhans cell histiocytosis. Targeting the membrane-proximal domain of CD33 to maximize the efficacy of natural killer cell-based immunotherapies. Ethnicity in systemic AL amyloidosis may impact risk stratification. High-dose intravenous immunoglobulin may be an efficient treatment option for patients with late-onset high-grade immune effector cell-associated hematotoxicity refractory to standard therapies.